Edgewise Therapeutics Inc [EWTX] stock prices are up 3.40% to $24.95 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EWTX shares have gain 8.76% over the last week, with a monthly amount glided 6.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on September 25, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $20. Previously, Raymond James started tracking the stock with Strong Buy rating on July 30, 2025, and set its price target to $46. On June 30, 2025, H.C. Wainwright initiated with a Buy rating and assigned a price target of $42 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $41 on April 30, 2025. Scotiabank downgraded its rating to a Sector Perform but $14 remained the price target by the analyst firm on April 02, 2025. Scotiabank started tracking with a Sector Outperform rating for this stock on March 07, 2025, and assigned it a price target of $50. In a note dated January 22, 2025, Stifel initiated a Hold rating and provided a target price of $30 on this stock.
The stock price of Edgewise Therapeutics Inc [EWTX] has been fluctuating between $10.60 and $30.48 over the past year. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $24.95 at the most recent close of the market. An investor can expect a potential drop of -19.84% based on the average EWTX price forecast.
Analyzing the EWTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.31 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Edgewise Therapeutics Inc [NASDAQ:EWTX]’s Current Ratio is 26.51. Also, the Quick Ratio is 26.51, while the Cash Ratio stands at 2.13.
Transactions by insiders
Recent insider trading involved ROBERT MICHAEL CARRUTHERS, Officer, that happened on Dec 26 ’25 when 0.12 million shares were purchased. Officer, ROBERT MICHAEL CARRUTHERS completed a deal on Nov 17 ’25 to buy 70000.0 shares. Meanwhile, Chief Scientific Officer Russell Alan J sold 100000.0 shares on Nov 12 ’25.
